Bradycardia can absolutely be genetic. Researchers have identified mutations in at least half a dozen genes that directly slow the heart’s electrical rhythm, and familial forms of both sinus bradycardia and sick sinus syndrome have been documented across multiple generations. That said, most cases of bradycardia in adults result from aging, medications, or high fitness levels rather than an inherited mutation. Understanding the genetic side matters most for people with unexplained bradycardia at a young age, a family history of pacemaker implantation, or newborns diagnosed with a slow heart rate before or shortly after birth.
Genes Linked to Inherited Bradycardia
Your heart’s rhythm depends on ion channels, tiny protein gates in cardiac cells that open and close to let charged particles flow in and out. This flow creates the electrical impulses that make the heart beat. When a gene that builds one of these channels carries a mutation, the channel may work too slowly, fail to reach the cell surface, or not respond to the body’s normal speed-up signals. The result is a heart that fires at a slower rate than it should.
The two most studied genes in inherited bradycardia are HCN4 and SCN5A. HCN4 produces the channel responsible for the “pacemaker current,” the spontaneous electrical activity in the sinus node that sets your resting heart rate. Several specific mutations in HCN4 have been found in families with sinus bradycardia. Some of these mutations make the channel insensitive to the chemical signals your body uses to speed up heart rate during exercise or stress, a problem called chronotropic incompetence. Others alter the channel’s structure so fewer functional copies reach the cell membrane. Some carriers have no symptoms at all, while others eventually need a pacemaker.
SCN5A encodes the main sodium channel in heart cells. Sodium channels don’t set the initial rhythm the way HCN4 does, but they’re essential for carrying each electrical impulse from the sinus node into the surrounding heart tissue. Loss-of-function mutations in SCN5A reduce the cell’s ability to fire and propagate signals, which can show up as bradycardia, conduction block, or both. More than 200 distinct SCN5A mutations have been cataloged, and at least 20 are associated with sick sinus syndrome specifically. The same gene is also linked to Brugada syndrome and long QT syndrome, so a single SCN5A mutation can produce overlapping heart rhythm problems within the same family.
Less common genetic culprits include mutations in KCNQ1 and KCNH2 (both potassium channel genes typically associated with long QT syndrome), connexin40 (a gene involved in cell-to-cell electrical coupling in the atria), and TRPM4 (linked to progressive heart block). In some families, bradycardia only appears when mutations in two different genes are inherited together. One well-studied example involves a sodium channel mutation in SCN5A combined with changes in the connexin40 gene’s regulatory region. Neither mutation alone consistently caused disease, but inheriting both led to complete electrical standstill in the atria.
How It Runs in Families
Familial sick sinus syndrome has been reported in both autosomal dominant and autosomal recessive inheritance patterns. In the dominant form, inheriting just one copy of the mutated gene from one parent is enough to cause bradycardia. In the recessive form, a child needs to inherit a defective copy from each parent. The dominant forms tend to involve HCN4 mutations, while some of the recessive cases involve compound mutations in SCN5A, where two different SCN5A variants are inherited together.
A complicating factor is something called incomplete penetrance. This means that not everyone who carries the mutation develops symptoms. In several studied families, some members with an SCN5A mutation had significant bradycardia requiring a pacemaker, while others with the exact same mutation had normal heart rates throughout life. Age plays a role too. Some carriers start with mild slowing that progresses over decades, eventually crossing the threshold into clinically significant bradycardia later in life. This makes genetic bradycardia easy to miss unless multiple family members are screened.
Bradycardia Present at Birth
Genetic bradycardia can appear remarkably early. Fetal bradycardia has been detected as early as 22 weeks of gestation in cases later confirmed to involve ion channel mutations. Congenital long QT syndrome is one of the more common genetic causes of neonatal bradycardia. In these babies, the heart’s electrical recovery phase is so prolonged that every other beat gets blocked, producing a pattern that looks like a very slow rhythm on monitoring.
Most of these neonatal cases have been linked to mutations in KCNH2, though SCN5A and KCNQ1 mutations have also been identified. One reported case involved a newborn delivered at 33 weeks whose slow heart rate was traced to a previously unreported variant in SCN5A through genetic testing. These cases are rare, but they illustrate that bradycardia with a genetic origin can be present from the very start of life, distinct from the more common cause of neonatal heart block related to maternal antibodies crossing the placenta.
The Genetic Side of Athletic Bradycardia
Endurance athletes commonly develop resting heart rates below 60 beats per minute, and this has traditionally been attributed entirely to training-induced changes in the heart and nervous system. Recent research published in Circulation suggests genetics plays a measurable role on top of fitness. In a study comparing athletes to healthy non-athletes, researchers used a polygenic risk score (a composite of many small genetic variants known to influence heart rate) and found that athletes as a group carried scores associated with naturally lower resting heart rates, even before accounting for their training.
Within the athletic cohort, those whose genetic scores fell in the bottom quartile (predisposing them to slower heart rates) had a median minimum heart rate of 41 beats per minute, compared with 45 bpm for those in the top quartile. After adjusting for age, sex, fitness level, and heart size, the genetic score independently doubled the odds of resting bradycardia. The researchers raised an intriguing possibility: people with a genetic predisposition toward lower heart rates may be drawn to endurance sports in the first place, partly because their cardiovascular system is naturally suited to it.
When Genetic Testing Makes Sense
Genetic testing for bradycardia isn’t routine. For an older adult whose heart rate has gradually slowed alongside normal aging or medication use, genetic testing rarely changes management. It becomes more relevant in specific scenarios: unexplained bradycardia in a young person, a family where multiple members have needed pacemakers, a newborn with fetal or neonatal bradycardia, or when bradycardia appears alongside other electrical abnormalities like a prolonged QT interval or Brugada pattern on an ECG.
Testing typically involves sequencing a panel of the known bradycardia-associated genes. A positive result can clarify the diagnosis, guide screening of other family members, and in some cases influence whether a pacemaker is recommended sooner rather than later. A negative result doesn’t rule out a genetic cause entirely, since not all relevant genes have been identified. But for families with a clear inherited pattern, even a negative test provides useful information for ongoing monitoring.